Justin Walsh
Stock Analyst at Jones Trading
(1.44)
# 3,423
Out of 4,915 analysts
40
Total ratings
36.11%
Success rate
-8.82%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| THTX Theratechnologies | Downgrades: Hold | n/a | $3.15 | - | 3 | Jul 3, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $122 → $109 | $71.84 | +51.73% | 9 | Jun 23, 2025 | |
| VNRX VolitionRx | Initiates: Buy | $3 | $0.70 | +327.35% | 1 | Jun 10, 2025 | |
| BLRX BioLineRx | Upgrades: Buy | $12 | $3.99 | +200.75% | 3 | May 30, 2025 | |
| CLNN Clene | Initiates: Buy | $30 | $3.49 | +759.60% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $42.66 | - | 1 | Apr 2, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $5.45 | +101.83% | 1 | Mar 11, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $18 | $3.07 | +486.32% | 1 | Dec 16, 2024 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $42 | $14.70 | +185.71% | 1 | Oct 18, 2024 | |
| YMAB Y-mAbs Therapeutics | Initiates: Buy | $23 | $4.79 | +380.17% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $3.88 | +467.01% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.42 | +261.99% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.67 | +649.06% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $0.93 | +331.08% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.92 | +410.20% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $2.21 | +714.48% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $440 | $1.84 | +23,813.04% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.46 | +16,300.61% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $32.69 | -38.82% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $1.71 | +11,595.91% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.05 | +227.87% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $800 | $6.20 | +12,803.23% | 1 | Sep 2, 2021 |
Theratechnologies
Jul 3, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.15
Upside: -
Lantheus Holdings
Jun 23, 2025
Maintains: Buy
Price Target: $122 → $109
Current: $71.84
Upside: +51.73%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $0.70
Upside: +327.35%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $3.99
Upside: +200.75%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $3.49
Upside: +759.60%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $42.66
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $5.45
Upside: +101.83%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $3.07
Upside: +486.32%
Rapport Therapeutics
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $14.70
Upside: +185.71%
Y-mAbs Therapeutics
Jul 11, 2024
Initiates: Buy
Price Target: $23
Current: $4.79
Upside: +380.17%
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $3.88
Upside: +467.01%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $4.42
Upside: +261.99%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $2.67
Upside: +649.06%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.93
Upside: +331.08%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $3.92
Upside: +410.20%
May 16, 2023
Initiates: Buy
Price Target: $18
Current: $2.21
Upside: +714.48%
Feb 10, 2023
Initiates: Buy
Price Target: $440
Current: $1.84
Upside: +23,813.04%
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $0.46
Upside: +16,300.61%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $32.69
Upside: -38.82%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $1.71
Upside: +11,595.91%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $3.05
Upside: +227.87%
Sep 2, 2021
Initiates: Buy
Price Target: $800
Current: $6.20
Upside: +12,803.23%